News

Metrics Names Stephanie Emory Associate Director of Pharma Development

Will direct team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials.

Curbing Malaria’s Spread by Genetic Engineering

Gene drives are being tested as a new approach for combatting the rise of mosquito resistance to pesticides and malaria parasite…

Merck cans one COVID-19 drug, scraps a clinical trial of another

Merck cans one COVID-19 drug, scraps a clinical trial of another

Alchemab completes £60m Series A funding to advance novel antibody platform

The funding will be used to advance Alchemab’s novel platform to identify disease-modifying antibody therapeutics

BioVersys Gets EIB Funds to Address Antimicrobial Resistance

Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumannii

Loss of Pleasure Linked to Early-Onset Dementia Not Alzheimer’s, New Study Finds

A new study from scientists at the University of Sydney, Australia, shows early-onset dementia or frontotemporal dementia (FTD) is…

GSK stops Keytruda combo trials after ICOS drug falls short

GSK stops Keytruda combo trials after ICOS drug falls short

Magic mushroom compound psilocybin shows ‘promise’ in depression

Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting




Contact Us